Replies to post #14686 on Cytodyn Inc (CYDY)

[Amatuer17]

Good that trial at least started but it is not a mover for SP due to its long duration

- Enrolling 60 patients may be more difficult than 30 patients for adjunct as it is not common condition
- as per original protocol - enrollment period was 1 year - so if everything goes right - Jun 2018
- primary out come 100 days after treatment
- secondary outcome- follow up 100 and 365 days - so 1 year after last patient dosing

Overall this product will be relevant in 2019 - if company can survive till that time

[buckysherm]

Thanks for posting, but what ?? I thought they started that a few months ago. Crap !